EAM
ANVS icon

Empery Asset Management’s Annovis Bio ANVS Stock Holding History

Empery Asset Management’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.47M Buy
+2,401,476
New +$4.67M 5.17% 6

Other funds holding ANVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FNT
First National Trust Hermitage, Pennsylvania $2.95B AUM 27.19% 1-Year Est. Return
SG
Sherry Group Mountain Home, Arkansas $102M AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.74B AUM 36.19% 1-Year Est. Return
WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.29B AUM 21.04% 1-Year Est. Return
DWM
Dakota Wealth Management Palm Beach Gardens, Florida $5.24B AUM 38.12% 1-Year Est. Return

Empery Asset Management's ANVS Position: Q2 2026 in Review

Empery Asset Management opened a new position in Annovis Bio (ANVS) in Q2 2026: 2,401,476 shares worth $4.47M. The stake represents 5.17% of the portfolio and ranks #6 among its holdings.

37 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Empery Asset Management held 2,401,476 shares of Annovis Bio worth $4.47M as of Q2 2026.
  • Annovis Bio was a new Empery Asset Management position in Q2 2026.
  • Annovis Bio made up 5.17% of Empery Asset Management's portfolio in Q2 2026, its #6 holding.
  • 37 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Empery Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.